LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY
To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KUROKAWA MITSUO KOZUKA HISASHI MATSUMOTO TAKUMI NAKAJIMA AKIRA |
| description | To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary crystalline phase. The main crystalline phase and the secondary crystalline phase in the lanthanum-molybdenum complex oxide can be specified by analyzing an X-ray diffraction spectrum obtained by powder X-ray diffractometry.SELECTED DRAWING: Figure 1
【課題】優れた抗菌性及び抗ウイルス性を併せ持ったランタン・モリブデン複合酸化物等の提供。【解決手段】ランタン・モリブデン複合酸化物は、Ｌａ２Ｍｏ２Ｏ９を主結晶相とし、前記Ｌａ２Ｍｏ２Ｏ９以外のランタン・モリブデン複合酸化物を副結晶相とするものであって、ランタン・モリブデン複合酸化物における主結晶相及び副結晶相は、粉末Ｘ線回折法により得られるＸ線回折スペクトルを解析することにより、特定することができる。【選択図】図１ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2022001542A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2022001542A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2022001542A3</originalsourceid><addsrcrecordid>eNrjZIjxcfQL8XD0C_XV9fX3iXRycQUyFZz9fQN8XCMU_CM8XVx1FIBKPJ0cnUNcgzwdfRSCPf2ALFcXBSd_l0iQpAtYQZhnELokDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J9wowMjAyMjAwNDUxcjQmShEALUsyvQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY</title><source>esp@cenet</source><creator>KUROKAWA MITSUO ; KOZUKA HISASHI ; MATSUMOTO TAKUMI ; NAKAJIMA AKIRA</creator><creatorcontrib>KUROKAWA MITSUO ; KOZUKA HISASHI ; MATSUMOTO TAKUMI ; NAKAJIMA AKIRA</creatorcontrib><description>To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary crystalline phase. The main crystalline phase and the secondary crystalline phase in the lanthanum-molybdenum complex oxide can be specified by analyzing an X-ray diffraction spectrum obtained by powder X-ray diffractometry.SELECTED DRAWING: Figure 1
【課題】優れた抗菌性及び抗ウイルス性を併せ持ったランタン・モリブデン複合酸化物等の提供。【解決手段】ランタン・モリブデン複合酸化物は、Ｌａ２Ｍｏ２Ｏ９を主結晶相とし、前記Ｌａ２Ｍｏ２Ｏ９以外のランタン・モリブデン複合酸化物を副結晶相とするものであって、ランタン・モリブデン複合酸化物における主結晶相及び副結晶相は、粉末Ｘ線回折法により得られるＸ線回折スペクトルを解析することにより、特定することができる。【選択図】図１</description><language>eng ; jpn</language><subject>CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY ; CHEMISTRY ; COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F ; INORGANIC CHEMISTRY ; METALLURGY ; PERFORMING OPERATIONS ; PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL ; THEIR RELEVANT APPARATUS ; TRANSPORTING</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220106&DB=EPODOC&CC=JP&NR=2022001542A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220106&DB=EPODOC&CC=JP&NR=2022001542A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KUROKAWA MITSUO</creatorcontrib><creatorcontrib>KOZUKA HISASHI</creatorcontrib><creatorcontrib>MATSUMOTO TAKUMI</creatorcontrib><creatorcontrib>NAKAJIMA AKIRA</creatorcontrib><title>LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY</title><description>To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary crystalline phase. The main crystalline phase and the secondary crystalline phase in the lanthanum-molybdenum complex oxide can be specified by analyzing an X-ray diffraction spectrum obtained by powder X-ray diffractometry.SELECTED DRAWING: Figure 1
【課題】優れた抗菌性及び抗ウイルス性を併せ持ったランタン・モリブデン複合酸化物等の提供。【解決手段】ランタン・モリブデン複合酸化物は、Ｌａ２Ｍｏ２Ｏ９を主結晶相とし、前記Ｌａ２Ｍｏ２Ｏ９以外のランタン・モリブデン複合酸化物を副結晶相とするものであって、ランタン・モリブデン複合酸化物における主結晶相及び副結晶相は、粉末Ｘ線回折法により得られるＸ線回折スペクトルを解析することにより、特定することができる。【選択図】図１</description><subject>CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</subject><subject>INORGANIC CHEMISTRY</subject><subject>METALLURGY</subject><subject>PERFORMING OPERATIONS</subject><subject>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</subject><subject>THEIR RELEVANT APPARATUS</subject><subject>TRANSPORTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIjxcfQL8XD0C_XV9fX3iXRycQUyFZz9fQN8XCMU_CM8XVx1FIBKPJ0cnUNcgzwdfRSCPf2ALFcXBSd_l0iQpAtYQZhnELokDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J9wowMjAyMjAwNDUxcjQmShEALUsyvQ</recordid><startdate>20220106</startdate><enddate>20220106</enddate><creator>KUROKAWA MITSUO</creator><creator>KOZUKA HISASHI</creator><creator>MATSUMOTO TAKUMI</creator><creator>NAKAJIMA AKIRA</creator><scope>EVB</scope></search><sort><creationdate>20220106</creationdate><title>LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY</title><author>KUROKAWA MITSUO ; KOZUKA HISASHI ; MATSUMOTO TAKUMI ; NAKAJIMA AKIRA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2022001542A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2022</creationdate><topic>CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F</topic><topic>INORGANIC CHEMISTRY</topic><topic>METALLURGY</topic><topic>PERFORMING OPERATIONS</topic><topic>PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL</topic><topic>THEIR RELEVANT APPARATUS</topic><topic>TRANSPORTING</topic><toplevel>online_resources</toplevel><creatorcontrib>KUROKAWA MITSUO</creatorcontrib><creatorcontrib>KOZUKA HISASHI</creatorcontrib><creatorcontrib>MATSUMOTO TAKUMI</creatorcontrib><creatorcontrib>NAKAJIMA AKIRA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KUROKAWA MITSUO</au><au>KOZUKA HISASHI</au><au>MATSUMOTO TAKUMI</au><au>NAKAJIMA AKIRA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY</title><date>2022-01-06</date><risdate>2022</risdate><abstract>To provide a lanthanum-molybdenum complex oxide etc. which has both an excellent antibacterial property and antiviral property.SOLUTION: A lanthanum-molybdenum complex oxide comprises La2Mo2O9 as a main crystalline phase and a lanthanum-molybdenum complex oxide other than the La2Mo2O9 as a secondary crystalline phase. The main crystalline phase and the secondary crystalline phase in the lanthanum-molybdenum complex oxide can be specified by analyzing an X-ray diffraction spectrum obtained by powder X-ray diffractometry.SELECTED DRAWING: Figure 1
【課題】優れた抗菌性及び抗ウイルス性を併せ持ったランタン・モリブデン複合酸化物等の提供。【解決手段】ランタン・モリブデン複合酸化物は、Ｌａ２Ｍｏ２Ｏ９を主結晶相とし、前記Ｌａ２Ｍｏ２Ｏ９以外のランタン・モリブデン複合酸化物を副結晶相とするものであって、ランタン・モリブデン複合酸化物における主結晶相及び副結晶相は、粉末Ｘ線回折法により得られるＸ線回折スペクトルを解析することにより、特定することができる。【選択図】図１</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2022001542A |
| source | esp@cenet |
| subjects | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOIDCHEMISTRY CHEMISTRY COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSESC01D OR C01F INORGANIC CHEMISTRY METALLURGY PERFORMING OPERATIONS PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL THEIR RELEVANT APPARATUS TRANSPORTING |
| title | LANTHANUM-MOLYBDENUM COMPLEX OXIDE, ANTIBACTERIAL SINTERED BODY, AND ANTIVIRAL SINTERED BODY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A51%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KUROKAWA%20MITSUO&rft.date=2022-01-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2022001542A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |